DELAWARE GROUP TAX FREE FUND
NSAR-B, EX-27.INSURED-C, 2000-10-31
Previous: DELAWARE GROUP TAX FREE FUND, NSAR-B, EX-27.INSURED-B, 2000-10-31
Next: ALPHARMA INC, 8-K, 2000-10-31



<TABLE> <S> <C>

<ARTICLE> 6
<CIK> 0000728352
<NAME> DELAWARE GROUP TAX-FREE FUND
<SERIES>
   <NUMBER> 023
   <NAME> DELAWARE TAX-FREE INSURED FUND C CLASS

<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          AUG-31-2000
<PERIOD-END>                               AUG-31-2000
<INVESTMENTS-AT-COST>                       63,251,181
<INVESTMENTS-AT-VALUE>                      66,262,799
<RECEIVABLES>                                1,141,326
<ASSETS-OTHER>                                       0
<OTHER-ITEMS-ASSETS>                           319,288
<TOTAL-ASSETS>                              67,723,413
<PAYABLE-FOR-SECURITIES>                             0
<SENIOR-LONG-TERM-DEBT>                              0
<OTHER-ITEMS-LIABILITIES>                      198,327
<TOTAL-LIABILITIES>                            198,327
<SENIOR-EQUITY>                             68,066,576
<PAID-IN-CAPITAL-COMMON>                             0
<SHARES-COMMON-STOCK>                           78,218
<SHARES-COMMON-PRIOR>                          144,960
<ACCUMULATED-NII-CURRENT>                            0
<OVERDISTRIBUTION-NII>                               0
<ACCUMULATED-NET-GAINS>                    (3,553,108)
<OVERDISTRIBUTION-GAINS>                             0
<ACCUM-APPREC-OR-DEPREC>                     3,011,618
<NET-ASSETS>                                   812,989
<DIVIDEND-INCOME>                                    0
<INTEREST-INCOME>                            4,187,366
<OTHER-INCOME>                                       0
<EXPENSES-NET>                                 706,553
<NET-INVESTMENT-INCOME>                      3,480,813
<REALIZED-GAINS-CURRENT>                     (824,214)
<APPREC-INCREASE-CURRENT>                      826,088
<NET-CHANGE-FROM-OPS>                        3,482,687
<EQUALIZATION>                                       0
<DISTRIBUTIONS-OF-INCOME>                       48,215
<DISTRIBUTIONS-OF-GAINS>                             0
<DISTRIBUTIONS-OTHER>                                0
<NUMBER-OF-SHARES-SOLD>                         31,861
<NUMBER-OF-SHARES-REDEEMED>                    102,784
<SHARES-REINVESTED>                              4,181
<NET-CHANGE-IN-ASSETS>                     (7,420,782)
<ACCUMULATED-NII-PRIOR>                              0
<ACCUMULATED-GAINS-PRIOR>                  (2,728,894)
<OVERDISTRIB-NII-PRIOR>                              0
<OVERDIST-NET-GAINS-PRIOR>                           0
<GROSS-ADVISORY-FEES>                          347,340
<INTEREST-EXPENSE>                                   0
<GROSS-EXPENSE>                                706,553
<AVERAGE-NET-ASSETS>                         1,117,362
<PER-SHARE-NAV-BEGIN>                           10.360
<PER-SHARE-NII>                                  0.432
<PER-SHARE-GAIN-APPREC>                          0.030
<PER-SHARE-DIVIDEND>                             0.432
<PER-SHARE-DISTRIBUTIONS>                        0.000
<RETURNS-OF-CAPITAL>                             0.000
<PER-SHARE-NAV-END>                             10.390
<EXPENSE-RATIO>                                  1.750



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission